Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 190 | 119 | 1,145 | 115 | 623 |
| Gross Profit | 190 | 119 | 1,145 | 115 | 623 |
| Operating Expenses | 3,032 | 3,969 | 3,661 | 3,476 | 3,027 |
| Operating Income | -2,842 | -3,850 | -2,516 | -3,361 | -2,404 |
| Other Income | 220 | 178 | 146 | 174 | 199 |
| Pre-tax Income | -2,622 | -3,672 | -2,370 | -3,187 | -2,206 |
| Net Income Continuous | -2,622 | -3,672 | -2,370 | -3,187 | -2,206 |
| Net Income | $-2,623 | $-3,672 | $-2,370 | $-3,187 | $-2,206 |
| EPS Basic Total Ops | -0.32 | -0.54 | -0.42 | -0.59 | -0.41 |
| EPS Basic Continuous Ops | -0.32 | -0.54 | -0.42 | -0.59 | -0.41 |
| EPS Diluted Total Ops | -0.32 | -0.54 | -0.42 | -0.59 | -0.41 |
| EPS Diluted Continuous Ops | -0.32 | -0.54 | -0.34 | -0.59 | -0.41 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.54 | -0.34 | -0.59 | -0.41 |
| EBITDA(a) | $-2,892 | $-3,931 | $-2,567 | $-3,381 | $-2,423 |